We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Top Buys

Rank Stock Value
1
CPN
Calpine Corporation
CPN
+$12.6M
2
MU icon
Micron Technology
MU
+$11.5M
3
SHPG
Shire pic
SHPG
+$8.7M
4
TWX
Time Warner Inc
TWX
+$8.39M
5
PRXL
Parexel International Corp
PRXL
+$7.95M

Top Sells

Rank Stock Value
1
MBLY
Mobileye N.V.
MBLY
+$25.8M
2
GTN icon
Gray Television
GTN
+$14.3M
3
NXPI icon
NXP Semiconductors
NXPI
+$12.3M
4
PNRA
Panera Bread Co
PNRA
+$11.7M
5
WOOF
VCA Inc.
WOOF
+$9.59M

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COWN
1551
DELISTED
Cowen Inc. Class A Common Stock
COWN
$2K ﹤0.01%
+100
New +$1.64K
VXX
1552
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$2K ﹤0.01%
51
-167
-77% -$7.75K
CPRX
1553
DELISTED
Catalyst Pharmaceutical
CPRX
$1K ﹤0.01%
270
-540
-67% -$1.48K
GERN icon
1554
Geron
GERN
$821M
$1K ﹤0.01%
372
-196
-35% -$462
SJT
1555
San Juan Basin Royalty Trust
SJT
$113M
$1K ﹤0.01%
+100
New +$701
TNDM icon
1556
Tandem Diabetes Care
TNDM
$1.38B
$1K ﹤0.01%
+77
New +$487
NBSE
1557
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1K ﹤0.01%
+3
New +$819
KDNY
1558
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
+19
New +$1.13K
SIOX
1559
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
12
-2,166
-99% -$365K
ALR
1560
DELISTED
AlerisLife Inc
ALR
$1K ﹤0.01%
50
– –
FWP
1561
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$1K ﹤0.01%
14
– –
ELGX
1562
DELISTED
Endologix Inc
ELGX
$1K ﹤0.01%
+21
New +$957
ECYT
1563
DELISTED
Endocyte, Inc. Common Stock
ECYT
$1K ﹤0.01%
600
-700
-54% -$975
LKM
1564
DELISTED
Link Motion Inc.
LKM
$1K ﹤0.01%
+200
New +$692
CCIH
1565
DELISTED
Chinacache International Holdings Ltd
CCIH
$1K ﹤0.01%
700
-200
-22% -$171
AAPL icon
1566
CALL
Apple
AAPL
$4.43T
– –
-36,000
Closed -$1.3M
AAPL icon
1567
Apple
AAPL
$4.43T
– –
-179,588
Closed -$6.47M
AAPL icon
1568
PUT
Apple
AAPL
$4.43T
– –
-36,000
Closed -$1.3M
ABBV icon
1569
AbbVie
ABBV
$433B
– –
-7,422
Closed -$538K
ABEV icon
1570
PUT
Ambev
ABEV
$47.1B
– –
-4,800
Closed -$26K
ACAD icon
1571
CALL
Acadia Pharmaceuticals
ACAD
$4.39B
– –
-32,000
Closed -$892K
ACHV icon
1572
Achieve Life Sciences
ACHV
$649M
– –
-3
Closed -$2K
ADBE icon
1573
Adobe
ADBE
$99.9B
– –
-5
Closed -$1K
ADI icon
1574
Analog Devices
ADI
$176B
– –
-827
Closed -$64K
ADVM
1575
DELISTED
Adverum Biotechnologies
ADVM
– –
-40
Closed -$1K
61 62
63
64 65

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.